Our study for the first time demonstrates that metformin exerts antitumor activity against high risk NB cells, reducing cell proliferation and viability, via inhibition of Akt phosphorylation, showing higher sensitivity for less differentiated, highly proliferative cells. Here, AKT1 is linked to neuroblastoma.